294 related articles for article (PubMed ID: 22069668)
1. Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.
Krakauer T
Toxins (Basel); 2010 Aug; 2(8):1963-83. PubMed ID: 22069668
[TBL] [Abstract][Full Text] [Related]
2. PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.
Krakauer T
Toxins (Basel); 2012 Nov; 4(11):1343-66. PubMed ID: 23202320
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutics targeting immune activation by staphylococcal superantigens.
Krakauer T
Med Sci Monit; 2005 Sep; 11(9):RA290-5. PubMed ID: 16127375
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock.
Krakauer T
Toxins (Basel); 2019 Mar; 11(3):. PubMed ID: 30909619
[TBL] [Abstract][Full Text] [Related]
5. Immune response to staphylococcal superantigens.
Krakauer T
Immunol Res; 1999; 20(2):163-73. PubMed ID: 10580640
[TBL] [Abstract][Full Text] [Related]
6. Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.
Krakauer T
Toxins (Basel); 2013 Sep; 5(9):1629-54. PubMed ID: 24064719
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal Superantigens Spark Host-Mediated Danger Signals.
Krakauer T; Pradhan K; Stiles BG
Front Immunol; 2016; 7():23. PubMed ID: 26870039
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock.
Krakauer T; Buckley M
Antimicrob Agents Chemother; 2006 Jan; 50(1):391-5. PubMed ID: 16377721
[TBL] [Abstract][Full Text] [Related]
9. FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights.
Krakauer T
Immunotargets Ther; 2017; 6():17-29. PubMed ID: 28497030
[TBL] [Abstract][Full Text] [Related]
10. Peptide antagonists of superantigen toxins.
Kaempfer R
Mol Divers; 2004; 8(2):113-20. PubMed ID: 15209162
[TBL] [Abstract][Full Text] [Related]
11. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
[TBL] [Abstract][Full Text] [Related]
12. Defense against biologic warfare with superantigen toxins.
Kaempfer R; Arad G; Levy R; Hillman D
Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
[TBL] [Abstract][Full Text] [Related]
13. The staphylococcal enterotoxin (SE) family: SEB and siblings.
Krakauer T; Stiles BG
Virulence; 2013 Nov; 4(8):759-73. PubMed ID: 23959032
[TBL] [Abstract][Full Text] [Related]
14. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
15. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
Arad G; Hillman D; Levy R; Kaempfer R
J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
[TBL] [Abstract][Full Text] [Related]
16. The bacterial superantigen and superantigen-like proteins.
Fraser JD; Proft T
Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
[TBL] [Abstract][Full Text] [Related]
17. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
18. Murine models of staphylococcal enterotoxin B-induced toxic shock.
Krakauer T; Buckley M; Fisher D
Mil Med; 2010 Nov; 175(11):917-22. PubMed ID: 21121506
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Tranter HS; Acharya KR
J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
[TBL] [Abstract][Full Text] [Related]
20. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
